Women's Health Initiative Clinical Trials: The Effects of Calcium and Vitamin D Supplementation and Hormone Therapy on LDL-Cholesterol and Other Cardiovascular Disease Risk Factors

Authors

Peter Schnatz, Reading Hospital, Thomas Jefferson UniversityFollow
Xuezhi Jiang, Reading Hospital, Thomas Jefferson UniversityFollow
Matthew Nudy, Penn State Hershey
David M O'Sullivan, Reading Hospital
Aaron K Aragaki, Fred Hutchinson Cancer Research Center, Seattle, WA
Mark Williams, Reading Hospital
Erin LeBlanc, Kaiser Permanente, Portland, Oregon
Lisa W Martin, George Washington University
JoAnn E Manson, Brigham and Women’s Hospital/Harvard Medical School, Boston MA
James M Shikany, University of Alabama, Birmingham
Karen C Johnson, University of Tennessee Health Science Center
Marcia L Stefanick, Stanford University
Martha E Payne, Duke University
Jane A Cauley, University of Pittsburgh
Barbara V Howard, MedStar Health Research
John Robbins, University of California, Davis

Document Type

Poster Presentation

Publication Date

12-2015

Publication Title

Menopause (New York, N.Y.)

Volume

22

Issue

12

Comments

Presented at the North American Menopause Society 26th Annual Meeting
Las Vegas, NV
September 30-October 3, 2015

Recommended Citation

Schnatz, P., Jiang, X., Nudy, M., O'Sullivan, D., Aragaki, A., Williams, M., LeBlanc, E., Martin, L., Manson, J., Shikany, J., Johnson, K., Stefanick, M., Payne, M., Cauley, J., Howard, B., & Robbins, J. (2015). Women's Health Initiative Clinical Trials: The Effects of Calcium and Vitamin D Supplementation and Hormone Therapy on LDL-Cholesterol and Other Cardiovascular Disease Risk Factors. Menopause (New York, N.Y.), 22 (12) Retrieved from https://scholarcommons.towerhealth.org/gme_ob_gyn_res_read/149